Skip to content

Participant login

Track sample status and get your results

Order tests, track orders, and get results

Providers
Patients
- Research Program
- Create Account
- Get Results
- FAQs
- Submit Request
- Diagnostics
- Resources
- FAQs
- Submit Request
Health Systems
- Diagnostic Testing
- Research
Press Releases
The Helix Research Network Adds Three New Health System Members, Transforming Clinical Genomics for Community Benefit
Read More
Life Sciences
Press Releases
Helix Partners with Komodo Health, Combining Helix's Clinico-Genomic Datasets with Komodo's Healthcare Map® for Clinical & Research Impact
Read More
Resources
- Media Library
- Webinars
- Videos
- Podcasts
- News & Press Releases
- In the news
- Press Releases
View All Resources
Videos
Partner Perspectives with Sanford Health
Watch Now
View All Resources
Company

Home
resources

Discover How Helix is Changing the World of Healthcare

Resources Hub

Get in touch

Weaving Genomics into the Fabric of Healthcare

Contact us:

Customer Support: (844) 211 2070 Monday - Friday: 6 AM – 6 PM (Pacific)

© 2016-2025 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

Resources

Blog
Research
All Resources

Who we serve

Health Systems
Life Sciences
Public Health

Company

About Us
News
Press Releases
Careers

Contact Us

Partnerships
Participant Support

Participant Support

Contact Support
Help Center

Privacy Notice
Terms of Service
Notice of Privacy Practices
Consumer Health Privacy Policy
Accessibility
Your Privacy Choices

CLIA #05D2117342
CAP #9382893

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

Power Window: a power-based sliding window method to identify the rare and novel variants underlying gene-based association signals

Research

Oct 26, 2022

Power Window: a power-based sliding window method to identify the rare and novel variants underlying gene-based association signals

Individuals with GCK-MODY are not at increased risk for common complications associated with T2D

Research

Oct 26, 2022

Individuals with GCK-MODY are not at increased risk for common complications associated with T2D

Combining breast cancer PRS & genes of intermediate penetrance improves risk stratification in the Healthy Nevada Project

Research

Oct 26, 2022

Combining breast cancer PRS & genes of intermediate penetrance improves risk stratification in the Healthy Nevada Project

The Role of Consensus in Building an Effective Health Equity Response

Blog

Oct 24, 2022

The Role of Consensus in Building an Effective Health Equity Response

Our Top Viral Surveillance Insights in Late October

Blog

Oct 21, 2022

Our Top Viral Surveillance Insights in Late October

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination

Research

Oct 19, 2022

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination

Cellpress

New Omicron Covid-19 Subvariants on the Rise in U.S., CDC Says

News

Oct 14, 2022

New Omicron Covid-19 Subvariants on the Rise in U.S., CDC Says

The Wall Street Journal

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

Research

Oct 8, 2022

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

Springer

CDC: Omicron Subvariants BA.4.6, BF.7 Increasing While BA.5 Declines

News

Oct 7, 2022

CDC: Omicron Subvariants BA.4.6, BF.7 Increasing While BA.5 Declines

US News & World Report

Page 16